ArticleJournal of general internal medicine2025
The Association Between Rapid Opioid Dose Tapering and Polydrug Overdose Deaths Among High-Dose, Long-Term Opioid Therapy Recipients.
Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPatients receiving high-dose, long-term opioid therapy (HDLTOT) who are subjected to rapid dose tapering may be at elevated risk of opioid withdrawal and illicit drug use that can lead to polydrug overdose.
objectiveWe aim to estimate the association between rapid tapering of HDLTOT and polydrug overdose death (POD) in a commercially insured cohort of North Carolina residents between 2006 and 2018.
designRetrospective cohort study.
participantsIn total, 21,478 commercially insured North Carolina residents aged 18-64 who received HDLTOT (≥ 90 morphine milligram equivalents for 90% of 90 consecutive days) before entering the cohort during 01/2006-09/2018. MAIN MEASURES: Time-varying binary exposure was assessed monthly as rapid opioid dose tapering or discontinuation ("rapid tapering") versus "no rapid tapering" (dose maintenance, gradual increase, or gradual reduction). POD was defined as overdose death involving at least two different substances (multiple opioids, multiple non-opioids, or a combination of opioids and non-opioids). We estimated risk differences (RD) and ratios (RRs) between rapid tapering and POD using inverse probability of treatment and censoring weighted Aalen-Johansen (AJ) and Fine-Gray (FG) estimators, accounting for time-varying confounding, informative censoring, and competing risk due to deaths of other causes. KEY
resultsDuring the 4-year follow-up of 21,478 patients who received HDLTOT, 255,091 person-months (47%) were exposed to rapid tapering and 26 POD events occurred in the study population. Compared to no rapid tapering, rapid tapering was associated with an elevated risk of POD at year 4 (AJ RD [95%CI]: 0.002 [0.0005, 0.004], FG RD [95%CI]:0.003 [0.0007, 0.005]), AJ RR [95%CI]: 3.26 [1.20, 8.81], FG RR [95%CI]: 3.23 [1.37, 7.60]).
conclusionsIncreased risk of polydrug overdose death at 4 years after rapid tapering of HDLTOT is consistent with the long-term safety concerns arising from rapid tapering among HDLTOT recipients, an important clinical consideration in the shared decision-making of pain management.
Indexed as
Identifiers
41430020What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.